Samantha Dowse | Managing Partner/ CMC Consultant
GreyRigge Associates Limited

Managing Partner and Consultant at GreyRigge Associates with experience spanning over 20 years’ working for Biopharmaceutical Companies including GlaxoSmithKline, Ipsen Biopharma, Lonza and Emergent Biosolutions. Skills Include:

Expertise in analytical development activities
CMC project management
Experienced analytical consultant- proven ability to develop successful tailored solutions
Extensive analytical development & validation expertise using statistical design
Technology transfer experience including negotiation/ management of CMOs
Robust design experience for stability, study management and analysis
Experience in CMC regulatory submission authoring and support
Outsourced & internal project management

Appearances:

Day 1 - Tuesday 14th October @ 11:30

Working Group 3: Making Vaccines Real: Aligning Science, Capital, and Supply Chains for Global Impact

This high-level discussion focuses on how to translate great science into usable vaccines - on time and at scale. With voices across the value chain, the panel will address:

Trends shaping investment and deal flow in vaccines
The role of flexible manufacturing and platform tech in pandemic preparedness
How innovators and CDMOs can co-develop agile, scalable solutions
Avoiding common CMC and process development disconnects
Creating alignment between product vision, patient need, and production capacity

Ideal for: Executives, BD leaders, CDMOs, policy makers, and global health stakeholders.

Session led by: